Supported By

Generic & Biosililar Medicines of Southern Africa (GBMSA)

About GBMSA:

Now rebranded as Generic and Biosimilar Medicines of Southern Africa (GBM), the National Association of Pharmaceutical Manufacturers (NAPM) was established in 1977 as a Section 21 Trade Association. It is a voluntary, non-profit organization whose members are South African and International Generics based Pharmaceutical manufacturers and distributors. The NAPM/GBM has a diverse membership comprising of manufacturing, importing and regulatory companies. Part of the NAPM/GBM’s function is to ensure that the sector plays a constructive role in our country’s economic growth, development and transformation and thereby create an environment in which the sector can thrive, expand, be competitive and enhance access of medicines to all of our country’s citizens.

(Generic BioSimilar Medicines of Southern Africa)
1342 Howick Mews, Waterfall Park,
Bekker Rd, Midrand, Postal: Box 32361,
Kyalami 1684 SOUTH AFRICA

TEL: +27.11.3126966